ArticleCureus2026
Efficacy of Intravenous Lidocaine Versus Ketorolac for Acute Pain Relief in Patients With Suspected Renal Colic Presenting to the Emergency Department at Pakistan Ordnance Factories (POF) Hospital, Wah Cantt, Pakistan.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRenal colic is a common urological emergency requiring prompt and effective analgesia. Although intravenous ketorolac is recommended as first-line therapy, its use may be limited in patients with contraindications to non-steroidal anti-inflammatory drugs (NSAIDs). Intravenous lidocaine has emerged as a potential non-opioid alternative. This study compared the analgesic efficacy and short-term safety of intravenous lidocaine with intravenous ketorolac in adults presenting with suspected renal colic.
methodsThis prospective, single-center, randomized controlled trial included 90 adults presenting to the emergency department with suspected renal colic and a Visual Analogue Scale (VAS) pain score of ≥7. Participants were randomly assigned to receive either intravenous lidocaine (1.5 mg/kg infused over 15 minutes; n = 45) or intravenous ketorolac (30 mg intravenous bolus; n = 45). The primary outcome was successful pain relief, defined as a reduction of at least three points on the VAS 30 minutes after treatment. Secondary outcomes included rescue analgesia requirements and adverse events.
resultsSuccessful pain relief was achieved in 31 patients (68.9%) in the lidocaine group and 27 patients (60.0%) in the ketorolac group (absolute risk difference 8.9%; 95% confidence interval, -10.8% to 28.6%; χ²(1) = 0.776, p = 0.378). Rescue analgesia was required in 14 patients (31.1%) receiving lidocaine and 18 patients (40.0%) receiving ketorolac. Adverse events were infrequent and mild, with transient dizziness reported in three patients receiving lidocaine and mild hypersensitivity reactions in two patients receiving ketorolac. No serious adverse events occurred.
conclusionsIntravenous lidocaine provided analgesic efficacy comparable to intravenous ketorolac for the management of suspected renal colic, with a similar short-term safety profile. Intravenous lidocaine may be considered a useful alternative for patients in whom NSAIDs are contraindicated or poorly tolerated. Larger multicenter studies are warranted to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.